U.S. Hemophilia Treatment Market АНАЛИЗ РАЗМЕРОВ И ДОЛЕЙ - ТЕНДЕНЦИИ РОСТА И ПРОГНОЗЫ (2024 - 2031)

U.S. Hemophilia Treatment Market is Segmented By Product Type (Recombinant Coagulation Factor, Plasma Derived Coagulation Factor, Antifibrinolytic Agents, and Others), By Disease Type (Hemophilia A, Hemophilia B, and Hemophilia C), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies). The report offers the value (in USD billion) for the above-mentioned segments.

U.S. Hemophilia Treatment Market Leaders

  • Takeda Pharmaceutical Компания Limited
  • Компания Sanofi Octapharma AG
  • Шведская компания Biovitrum AB
  • Компания Baxter International Инк.
  • Biogen Inc.
*Disclaimer: Major players are listed in no particular order.

U.S. Hemophilia Treatment Market - Company List

  • Takeda Pharmaceutical Компания Limited
  • Компания Sanofi Octapharma AG
  • Шведская компания Biovitrum AB
  • Компания Baxter International Инк.
  • Biogen Inc.
  • Bayer AG AG
  • CSL Беринг
  • Ферринг Б.В.
  • Pfizer, Inc.
  • Кедрион
  • Ново Нордиск A/S
  • Грифолс С.А.
  • Sangamo Therapeutics, Inc.
  • Spark Therapeutics, Inc.

U.S. Hemophilia Treatment Market Report Snapshots

Buy Now